DuPont de Nemours, Inc. Healthcare Technologies — Net Sales increased by 11.5% to $467.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.5%, from $419.00M to $467.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market adoption of the segment's healthcare solutions or successful expansion into new medical applications, while a decrease may signal competitive pressure, product obsolescence, or reduced demand in healthcare end-markets.
This metric represents the total revenue generated from the sale of goods and services within the healthcare technologie...
Comparable to revenue metrics for life sciences or medical material divisions at diversified chemical or specialty material companies.
dd_segment_healthcare_technologies_net_sales| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $364.75M | $364.75M | $364.75M | $364.75M | $392.00M | $392.00M | $392.00M | $392.00M | $419.00M | $467.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.5% | +0.0% | +0.0% | +0.0% | +6.9% | +11.5% |
| YoY Change | — | — | — | — | +7.5% | +7.5% | +7.5% | +7.5% | +6.9% | +11.5% |